Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;9(2):95-101.
doi: 10.3400/avd.oa.16-00009. Epub 2016 Apr 26.

Effects of Preoperative Glycyrrhizin Infusion for the Prevention of Venous Thrombosis on the Tissue Expression of Antithrombin in a Rat Model

Nobuaki Nakata  1 , Yukimi Kira  2
Affiliations

Effects of Preoperative Glycyrrhizin Infusion for the Prevention of Venous Thrombosis on the Tissue Expression of Antithrombin in a Rat Model

Nobuaki Nakata et al. Ann Vasc Dis. 2016.

Abstract

Objective: Using a thrombus model prepared by ligation of the inferior vena cava (IVC), the influences of the glycoside, glycyrrhizin, on plasma antithrombin levels and antithrombin mRNA expression levels in the liver and IVC with the inhibition of venous thrombosis were investigated.

Materials and methods: The rat IVC was exposed and ligated for 24 h immediately after the intravenous administration of 300 mg/kg glycyrrhizin. Among antithrombotic drugs, the Xa inhibitor, fondaparinux sodium, was used as a control drug.

Results: The mean thrombus weight was significantly smaller in the glycyrrhizin-treated group (18.3 mg) than in the saline-treated group (34.3 mg). In contrast, the inhibition of thrombosis was not observed in the fondaparinux-treated group. Antithrombin mRNA expression levels in the liver were significantly higher in the ligated groups than in the baseline control group. The mean plasma antithrombin level was significantly lower in the glycyrrhizin group (96.6%) than in the saline group (114.4%), but was not significantly different from that in the baseline control group (102.4%).

Conclusion: The pretreatment with glycyrrhizin inhibited venous thrombosis, and antithrombin mRNA expression levels in the liver and IVC as well as plasma antithrombin levels were significantly lower than those in the saline group.

Keywords: DVT; antithrombin; glycyrrhizin.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Comparison of effects of glycyrrhizin (n = 7) and saline (n = 7) on plasma concentrations of antithrombin; *P = 0.01, No. of baseline control rats (n = 7). (B) Comparison of effects of fondaparinux (n = 7) and saline (n = 6) on the plasma concentration of antithrombin; No. of baseline control rats (n = 7). *1 P = 0.0053; *2 P = 0.0298.
Fig. 2
Fig. 2
Relative ratios of antithrombin mRNA expression in the liver among baseline control (n = 5), saline-treated (n = 6), and glycyrrhizin-treated rats (n = 7); *1 P = 0.0062; *2 P = 0.0027; *3 P = 0.0045.
Fig. 3
Fig. 3
Relative ratios of antithrombin mRNA expression in the liver among baseline control (n = 4), saline-treated (n = 6), and fondaparinux-treated rats (n = 7); *1 P = 0.011; *2 P = 0.008.
Fig. 4
Fig. 4
Relative ratios of antithrombin mRNA expression in the IVC vein wall among baseline control (n = 5), saline-treated (n = 6), and glycyrrhizin-treated rats (n = 7). *1 P = 0.044; *2 P = 0.032. IVC: inferior vena cava
Fig. 5
Fig. 5
Relative ratios of antithrombin mRNA expression in the IVC vein wall among baseline control (n = 4), saline-treated (n = 6), and fondaparinux-treated rats (n = 7). *1 P = 0.011; *2 P = 0.008. IVC: inferior vena cava
See this image and copyright information in PMC

References

    1. Zhang W, Swanson R, Izaguirre G, et al. The heparin-binding site of antithrombin is crucial for antiangiogenic activity. Blood 2005; 106: 1621-8. - PMC - PubMed
    1. Vinazzer H. Clinical use of antithrombin III concentrates. Vox Sang 1987; 53: 193-8. - PubMed
    1. Griffith MJ. Kinetic analysis of the heparin-enhanced antithrombin III/thrombin reaction. Reaction rate enhancement by heparin-thrombin association. J Biol Chem 1979; 254: 12044-9. - PubMed
    1. Kyriakides C, Wang Y, Austen WG, et al. Moderation of skeletal muscle reperfusion injury by a sLe(x)-glycosylated complement inhibitory protein. Am J Physiol, Cell Physiol 2001; 281: C224-30. - PubMed
    1. Thiagarajan RR, Winn RK, Harlan JM. The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost 1997; 78: 310-4. - PubMed

LinkOut - more resources